1. Israel Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc.

PLX.TA
Protalix BioTherapeutics, Inc.IL flagTel Aviv Stock Exchange
732.50
ILA
- -
- -
42.03BMarket Cap

Total Valuation

Protalix BioTherapeutics, Inc. carries a market capitalization of 42.03B, placing it among publicly traded companies globally.

Market Cap42.03B
Enterprise ValueN/A

Stock Price Statistics

Protalix BioTherapeutics, Inc.'s stock has gained approximately 68.97347% over the past 52 weeks. The 50-day moving average sits at 602.06, while the 200-day moving average is 438.21.

Beta (5Y)N/A
52-Week Price Change68.97347%
50-Day Moving Average602.06
200-Day Moving Average438.21
Average Volume (20 Days)N/A

Stock Splits

Protalix BioTherapeutics, Inc.'s most recent stock split took place on December 22, 2019 with a 10:1 split ratio.

Last Split Date12/22/2019
Split Ratio10:1